An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults
- 29 December 1999
- journal article
- clinical trial
- Published by Elsevier BV in Vaccine
- Vol. 18 (14), 1312-1319
- https://doi.org/10.1016/s0264-410x(99)00415-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pertussis in adults: frequency of transmission after household exposureThe Lancet, 1995
- Pertussis Infection among Adults during the 1993 Outbreak in ChicagoThe Journal of Infectious Diseases, 1995
- Outbreak of pertussis in highly immunized adolescents and its secondary spread to their familiesPediatrics International, 1995
- Symptoms and complications of pertussis in adultsInfection, 1995
- Pertussis in Massachusetts, 1981-1991: Incidence, Serologic Diagnosis, and Vaccine EffectivenessThe Journal of Infectious Diseases, 1994
- Outbreak of Pertussis in a Fully Immunized Adolescent and Adult PopulationArchives of Pediatrics & Adolescent Medicine, 1994
- Epidemiological Features of Pertussis in the United States, 1980-1989Clinical Infectious Diseases, 1992
- A Search for Bordetella pertussis Infection in University StudentsClinical Infectious Diseases, 1992
- Pertussis Encephalopathy in an Adult: Case Report and ReviewClinical Infectious Diseases, 1991
- Whooping cough in adults.BMJ, 1981